{"id":23338,"date":"2021-01-19T13:19:41","date_gmt":"2021-01-19T12:19:41","guid":{"rendered":"https:\/\/staging.capitalmind.com\/deals\/novartis-cede-deux-sites-en-espagne\/"},"modified":"2021-06-12T01:14:30","modified_gmt":"2021-06-11T23:14:30","slug":"novartis-cede-deux-sites-en-espagne","status":"publish","type":"deals","link":"https:\/\/dev2.capitalmind.com\/fr\/deals\/novartis-cede-deux-sites-en-espagne\/","title":{"rendered":"Novartis c\u00e8de deux usines \u00e0 Siegfried"},"content":{"rendered":"<h2>Contexte de l&rsquo;op\u00e9ration<\/h2>\n<p>Novartis a c\u00e9d\u00e9 \u00e0 Siegfried Holding AG, un sous-traitant de l&rsquo;industrie pharmaceutique, deux de ses usines en Espagne. Les deux sites de production, en r\u00e9gion barcelonaise, fabriquent avec leur millier d&#8217;employ\u00e9s des enveloppes ophtalmiques st\u00e9riles, des g\u00e9lules ainsi que des capsules destin\u00e9es aux dispositifs d&rsquo;inhalation. L&rsquo;int\u00e9gration de ces deux sites doit permettre \u00e0 Siegfried de g\u00e9n\u00e9rer d\u00e8s l&rsquo;exercice 2021 plus d&rsquo;un milliard de francs suisses de chiffre d&rsquo;affaires.<\/p>\n<p>Novartis, avec cette cession, poursuit sa strat\u00e9gie de recentrer sa gamme sur des m\u00e9dicaments plus strat\u00e9giques.<\/p>\n<h2>Notre r\u00f4le<\/h2>\n<p>Investec a conseill\u00e9 Novartis tout au long du process de cession : coordination des phases de Due Diligence, travail sur le carve-out, cr\u00e9ation de la documentation marketing, assistance dans la n\u00e9gociation de la transaction et de la documentation juridique.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Contexte de l&rsquo;op\u00e9ration Novartis a c\u00e9d\u00e9 \u00e0 Siegfried Holding AG, un sous-traitant de l&rsquo;industrie pharmaceutique, deux de ses usines en&#8230;<\/p>\n","protected":false},"featured_media":23243,"template":"","dt":[],"sector":[3768,3711],"dealtype":[3721,3706],"clienttype":[3733],"class_list":["post-23338","deals","type-deals","status-publish","has-post-thumbnail","hentry","sector-healthcare-fr","sector-industrie-fr","dealtype-carve-out-fr","dealtype-cession-fr","clienttype-grands-groupes-fr"],"acf":[],"_links":{"self":[{"href":"https:\/\/dev2.capitalmind.com\/fr\/wp-json\/wp\/v2\/deals\/23338","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dev2.capitalmind.com\/fr\/wp-json\/wp\/v2\/deals"}],"about":[{"href":"https:\/\/dev2.capitalmind.com\/fr\/wp-json\/wp\/v2\/types\/deals"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dev2.capitalmind.com\/fr\/wp-json\/wp\/v2\/media\/23243"}],"wp:attachment":[{"href":"https:\/\/dev2.capitalmind.com\/fr\/wp-json\/wp\/v2\/media?parent=23338"}],"wp:term":[{"taxonomy":"dt","embeddable":true,"href":"https:\/\/dev2.capitalmind.com\/fr\/wp-json\/wp\/v2\/dt?post=23338"},{"taxonomy":"sector","embeddable":true,"href":"https:\/\/dev2.capitalmind.com\/fr\/wp-json\/wp\/v2\/sector?post=23338"},{"taxonomy":"dealtype","embeddable":true,"href":"https:\/\/dev2.capitalmind.com\/fr\/wp-json\/wp\/v2\/dealtype?post=23338"},{"taxonomy":"clienttype","embeddable":true,"href":"https:\/\/dev2.capitalmind.com\/fr\/wp-json\/wp\/v2\/clienttype?post=23338"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}